Razupenem

Drug Profile

Razupenem

Alternative Names: PTZ601; PZ-601; SM-216601; SMP-216601; SMP-601

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Sumitomo Pharma
  • Developer Dainippon Sumitomo Pharma; Protez Pharmaceuticals
  • Class Antibacterials; Carbapenems; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bacterial infections; Gram-positive infections
  • Discontinued Gram-negative infections; Nosocomial infections; Skin and soft tissue infections

Most Recent Events

  • 22 May 2012 No development reported - Preclinical for Bacterial infections in Japan (IV)
  • 22 May 2012 No development reported - Preclinical for Gram-positive infections in Japan (IV)
  • 15 Sep 2009 Pharmacodynamics data from a preclinical trial in Gram-positive and Gram-negative infections presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2009)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top